Agalsidase beta Completed Phase N/A Trials for Fabry's Disease / Proteinuria

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00446862The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
NCT02969200Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance